In AML patients, transcripts of the mutant NPM1 gene in peripheral blood are an indication of minimal residual disease and this is a prognostic marker independent of further genetic changes and other parameters.
In AML patients, transcripts of the mutant NPM1 gene in peripheral blood are an indication of minimal residual disease and this is a prognostic marker independent of further genetic changes and other parameters.